NasdaqCM - Nasdaq Real Time Price • USD
Benitec Biopharma Inc. (BNTC)
As of 12:01 PM EDT. Market Open.
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Cash Flow
-18,066.00
-18,012.00
-15,899.00
-12,832.00
-7,535.00
Investing Cash Flow
-1.00
-1.00
-13.00
-221.00
-94.00
Financing Cash Flow
27,958.00
16,015.00
--
22,522.00
1,770.00
End Cash Position
20,442.00
2,490.00
4,076.00
19,784.00
9,801.00
Capital Expenditure
--
-1.00
-13.00
-221.00
-95.00
Issuance of Capital Stock
30,922.00
17,884.00
--
25,750.00
2,250.00
Free Cash Flow
-18,067.00
-18,013.00
-15,912.00
-13,053.00
-7,630.00
6/30/2020 - 6/24/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BPTH Bio-Path Holdings, Inc.
2.7400
-6.16%
NKGN NKGen Biotech, Inc.
1.6901
+14.95%
PALI Palisade Bio, Inc.
6.25
+26.78%
BRTX BioRestorative Therapies, Inc.
1.3900
+1.46%
CLNN Clene Inc.
0.3360
+0.90%
MLEC Moolec Science SA
1.8200
-26.32%
ALRN Aileron Therapeutics, Inc.
4.7100
-0.84%
VNDA Vanda Pharmaceuticals Inc.
4.7700
-0.63%
LGVN Longeveron Inc.
1.8150
-2.94%
SNGX Soligenix, Inc.
0.4012
-1.13%